跳至主要内容
临床试验/NCT04260048
NCT04260048已完成不适用

Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children

University of Washington2 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2020年2月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
101
试验地点
2
主要终点
Hypothalamic gliosis

研究概览

简要总结

BEAM is a multi-site longitudinal cohort study of hypothalamic gliosis, central regulation of appetite and weight gain in children. Participants will be recruited from the community in the greater Seattle and greater Baltimore area. All participants will consent to enroll in the 24-month study during which they will complete 5 in-person study visits.

详细描述

The proposed 2-site research study uses a longitudinal cohort design in 102 children aged 9-11 yr. It will include for all participants baseline MRI and functional MRI, in-depth eating behavior testing, and measurement of hormone profiles. Serial measurement of weight and self-reported eating habits will occur over 2 yr, with a repeated MRI at 2 yr. The study aims to: 1) test if MBH gliosis is associated with impaired intake regulation and poor weight outcomes over 2 yr in children, 2) determine if CNS appetitive processing is negatively affected when evidence of MBH gliosis is present, and 3) test for other brain regions in which gliosis is present in association with excess adiposity in children. An exploratory aim will assess changes in gliosis in children over 2 yr and their relation to changes in body weight and adiposity.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
9 Years 至 11 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 9-11 y (at time of enrollment)
  • BMI ≥ 15th percentile for age and sex

排除标准

  • Significant Health conditions (e.g., type 2 diabetes)
  • Documented cognitive disorder
  • History of major weight loss of 10lbs or more, not due to illness, over the past year
  • Eating disorder (e.g. anorexia, bulimia)
  • Current use of medications known to alter appetite, body weight or brain response including: Anti-epileptics; Glucocorticoids; Antipsychotics; Stimulants for ADHD
  • MRI contraindication (e.g. implanted metal, claustrophobia, inability to fit in MRI scanner)
  • Weight >330 pounds (MRI limit)
  • Severe food allergies, vegetarian, or vegan, or unable to eat study foods
  • Currently in formal weight loss program

结局指标

主要结局

Hypothalamic gliosis

时间窗: 2 years

Evidence of hypothalamic gliosis as measured by T2 relaxation time using MRI

Habitual dietary intake

时间窗: 2 years

Dietary intake in children by 24-hour dietary recalls

Obesity

时间窗: 2 years

Child BMI z-score calculated by the measures of height and weight

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ellen Schur, MD, MS

Associate Professor, School of Medicine

University of Washington

研究点 (2)

Loading locations...

相似试验